PAKOLA STEVE (Chief Medical Officer) sold 6.2% of their position (15.31K shares) of REGENXBIO INC. on the open market
Open‑market sale worth $168.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/13/2026ACC: 0001700659-26-000010
Officer· Chief Medical Officer
Since Apr 2019
-15.31K
Net shares
Net seller
$168.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
15.31K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−15.31K
Price / share
$11.02
Trade value
$168.71K
% of position
6.2%
5/11/2026
247.93K→232.62K
Total
Net shares
−15.31K
Net value
-$168.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | S · Sale | −15.31K | $11.02 | $168.71K | 6.2% | 247.93K | 232.62K |
| Total | −15.31K | -$168.71K | ||||||
Derivative Transactions0
No derivative transactions reported